Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Oliver, R T D; Mason, M D; Mead, G M; von der Maase, H; Rustin, G J S; Joffe, J K; de Wit, R; Aass, N; Graham, J D; Coleman, R; Kirk, S J; Stenning, S P

Oliver, R T D; Mason, M D; Mead, G M; von der Maase, H; Rustin, G J S; Joffe, J K; de Wit, R; Aass, N; Graham, J D; Coleman, R; Kirk, S J; Stenning, S P.

Affiliation

Oliver RT; Department of Medical Oncology, St Bart's and the London Hospital, London EC1A 7BE, UK. r.t.oliver@qmul.ac.uk

Lancet ; 366(9482): 293-300, 2005.

Article in En | MEDLINE | ID: mdl-16039331

Subject(s)

Antineoplastic Agents/administration & dosage; Carboplatin/administration & dosage; Seminoma/drug therapy; Testicular Neoplasms/drug therapy; Adult; Chemotherapy, Adjuvant; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Orchiectomy; Radiotherapy, Adjuvant; Seminoma/mortality; Seminoma/radiotherapy; Seminoma/surgery; Survival Rate; Testicular Neoplasms/mortality; Testicular Neoplasms/radiotherapy; Testicular Neoplasms/surgery

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Carboplatin / Seminoma / Antineoplastic Agents Type of study: Clinical_trials / Guideline Limits: Adult / Humans / Male Language: En Journal: Lancet Year: 2005 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links